| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-96 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 |
| filingDate |
1997-11-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dd8673a529a3a8dfe6e140a5a4a4214 |
| publicationDate |
1998-06-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9823643-A1 |
| titleOfInvention |
Multimeric erythropoietin with increased biological activity |
| abstract |
Modified polypeptides with increased biological activity exhibited as either increased potency or prolonged circulating half-life are disclosed with methods of preparing the modified polypeptides and methods of use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008546732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009529509-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9938891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6107272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010189405-A |
| priorityDate |
1996-11-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |